147 related articles for article (PubMed ID: 27105205)
1. Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Through a Therapeutic Educational Approach: A Feasibility Study
.
Bourmaud A; Rousset V; Regnier-Denois V; Collard O; Jacquin JP; Merrouche Y; Lapoirie J; Tinquaut F; Lataillade L; Chauvin F
Oncol Nurs Forum; 2016 May; 43(3):E94-E103. PubMed ID: 27105205
[TBL] [Abstract][Full Text] [Related]
2. Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer.
Sommers RM; Miller K; Berry DL
Oncol Nurs Forum; 2012 Jul; 39(4):E373-9. PubMed ID: 22750908
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
4. A Structured Nursing Intervention to Address Oral Chemotherapy Adherence in Patients With Non-Small Cell Lung Cancer.
Boucher J; Lucca J; Hooper C; Pedulla L; Berry DL
Oncol Nurs Forum; 2015 Jul; 42(4):383-9. PubMed ID: 26148317
[TBL] [Abstract][Full Text] [Related]
5. Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer.
Bender CM; Gentry AL; Brufsky AM; Casillo FE; Cohen SM; Dailey MM; Donovan HS; Dunbar-Jacob J; Jankowitz RC; Rosenzweig MQ; Sherwood PR; Sereika SM
Oncol Nurs Forum; 2014 May; 41(3):274-85. PubMed ID: 24769592
[TBL] [Abstract][Full Text] [Related]
6. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.
Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK
Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973
[TBL] [Abstract][Full Text] [Related]
7. Physical activity in women receiving chemotherapy for breast cancer: adherence to a walking intervention.
Swenson KK; Nissen MJ; Henly SJ
Oncol Nurs Forum; 2010 May; 37(3):321-30. PubMed ID: 20439216
[TBL] [Abstract][Full Text] [Related]
8. The attitudes, communication, treatment, and support intervention to reduce breast cancer treatment disparity.
Rosenzweig M; Brufsky A; Rastogi P; Puhalla S; Simon J; Underwood S
Oncol Nurs Forum; 2011 Jan; 38(1):85-9. PubMed ID: 21186164
[TBL] [Abstract][Full Text] [Related]
9. Randomized Controlled Pilot Trial of a Low-Touch Remotely-Delivered Values Intervention to Promote Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors.
Arch JJ; Crespi CM; Levin ME; Genung SR; Nealis M; Mitchell JL; Bright EE; Albright K; Magidson JF; Stanton AL
Ann Behav Med; 2022 Aug; 56(8):856-871. PubMed ID: 35323853
[TBL] [Abstract][Full Text] [Related]
10. Informing women with breast cancer about endocrine therapy: effects on knowledge and adherence.
Heisig SR; Shedden-Mora MC; von Blanckenburg P; Schuricht F; Rief W; Albert US; Nestoriuc Y
Psychooncology; 2015 Feb; 24(2):130-7. PubMed ID: 24953538
[TBL] [Abstract][Full Text] [Related]
11. Adherence, sleep, and fatigue outcomes after adjuvant breast cancer chemotherapy: results of a feasibility intervention study.
Berger AM; VonEssen S; Kuhn BR; Piper BF; Agrawal S; Lynch JC; Higginbotham P
Oncol Nurs Forum; 2003; 30(3):513-22. PubMed ID: 12719750
[TBL] [Abstract][Full Text] [Related]
12. The Experience of Initiating Oral Adjuvant Treatment for Estrogen Receptor-Positive Breast Cancer.
Flanagan J; Tetler D; Winters L; Post K; Habin K
Oncol Nurs Forum; 2016 Jul; 43(4):E143-52. PubMed ID: 27314197
[TBL] [Abstract][Full Text] [Related]
13. Endocrine therapy in breast cancer: the neoadjuvant, adjuvant, and metastatic approach.
Reinbolt RE; Mangini N; Hill JL; Levine LB; Dempsey JL; Singaravelu J; Koehler KA; Talley A; Lustberg MB
Semin Oncol Nurs; 2015 May; 31(2):146-55. PubMed ID: 25951743
[TBL] [Abstract][Full Text] [Related]
14. A mixed-methods study of the technical feasibility and patient acceptability of a real-time adherence monitor in breast cancer survivors taking adjuvant endocrine therapy.
Bright EE; Genung SR; Stanton AL; Arch JJ
Breast Cancer Res Treat; 2022 Oct; 195(3):393-399. PubMed ID: 35962148
[TBL] [Abstract][Full Text] [Related]
15. Adherence to oral endocrine therapy for breast cancer: a nursing perspective.
Miaskowski C; Shockney L; Chlebowski RT
Clin J Oncol Nurs; 2008 Apr; 12(2):213-21. PubMed ID: 18390458
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer.
Yates P; Aranda S; Hargraves M; Mirolo B; Clavarino A; McLachlan S; Skerman H
J Clin Oncol; 2005 Sep; 23(25):6027-36. PubMed ID: 16135471
[TBL] [Abstract][Full Text] [Related]
17. Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey.
Tinari N; Fanizza C; Romero M; Gambale E; Moscetti L; Vaccaro A; Seminara P; Longo F; Gori S; Vici P; Gamucci T; Mauri M; Laudadio L; Nuzzo A; Fabbri MA; Fattoruso SI; Mazzilli L; Grassadonia A; Cianchetti E; Natoli C
Clin Breast Cancer; 2015 Apr; 15(2):e131-7. PubMed ID: 25454738
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer patients' experiences of adherence and persistence to oral endocrine therapy: A qualitative evidence synthesis.
Clancy C; Lynch J; OConnor P; Dowling M
Eur J Oncol Nurs; 2020 Feb; 44():101706. PubMed ID: 32007696
[TBL] [Abstract][Full Text] [Related]
19. Factors perceived to influence exercise adherence in women with breast cancer participating in an exercise programme during adjuvant chemotherapy: a focus group study.
Husebø AM; Karlsen B; Allan H; Søreide JA; Bru E
J Clin Nurs; 2015 Feb; 24(3-4):500-10. PubMed ID: 24890796
[TBL] [Abstract][Full Text] [Related]
20. Feasibilty of a sleep intervention during adjuvant breast cancer chemotherapy.
Berger AM; VonEssen S; Khun BR; Piper BF; Farr L; Agrawal S; Lynch JC; Higginbotham P
Oncol Nurs Forum; 2002; 29(10):1431-41. PubMed ID: 12432414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
